No image available for this title

LITERATURE

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial


Angiotensin-converting enzyme (ACE) inhibitors reduce major cardiovascular events, but are not
tolerated by about 20% of patients. We therefore assessed whether the angiotensin-receptor blocker telmisartan
would be eff ective in patients intolerant to ACE inhibitors with cardiovascular disease or diabetes with end-organ
damage.


Availability

Telmisartan OGB-01Available

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
-
Specific Detail Info
Lancet 2008; 372: 1174–83
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous